Accuracy of preoperative magnetic resonance imaging in assessing lymph node metastasis and myometrial invasion in patients with uterine cancer

European Journal of Gynaecological Oncology

Volumn 30, Issue 2, 2009, Pages 167-170

  Yoo, S C ^a   Kim, W Y ^a   Yoon, J H ^a   Kim, H Y ^a   Lee, E J ^a   Chang, S J ^a   Chang, K H ^a   Ryu, H S ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Lymph node metastasis; Magnetic resonance image (MRI); Myometrial invasion; Uterine cancer

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; DIAGNOSTIC ACCURACY; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIXED TUMOR; MYOMETRIAL INVASION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLARY CARCINOMA; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PREDICTION; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; UTERUS CANCER; UTERUS SARCOMA;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; PELVIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 65349194436     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M. J.: "Cancer statistics, 2007". CA Cancer J. Clin., 2007, 57, 43.
2. Annual Report of Gynecologic Cancer Registry Program in Korea for 2004 (2004. 1. 1-2004. 12. 31). Korean J. Obstet. Gynecol., 2007, 50, 28.
3. Podratz K.C., Mariani A., Webb M.J.: "Staging and therapeutic value of lymphadenectomy in endometrial cancer". Gynecol. Oncol., 1998, 70, 163.
4. Candiani G.B., Belloni C., Maggi R., Colombo G., Frigoli A., Carinelli S.G.: "Evaluation of different surgical approaches in the treatment of endometrial cancer at FIGO Stage I". Gynecol. Oncol., 1990, 37, 6.
5. Mariani A., Webb M.J., Keeney G.L., Calori G., Podratz K.C.: "Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement". Gynecol. Oncol., 2001, 83, 72.
6. Chung H.H., Kang S.B., Cho J.Y., Kim J.W., Park N.H., Song Y.S. et al.: "Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer?". Jpn J. Clin. Oncol., 2007, 37, 370.
7. Kim E.A. C.H., Lee S.O., Kim Y.S., Park H.M., Mun H.S. et al.: "The Clinical Significance of Computed Tomography and Magnetic Resonance Imaging in Pretreatment Evaluation of Invasive Cervical Cancer". Korean J. Obstet. Gynecol., 2003, 46, 2162.
8. Reinhardt M.J., Ehritt-Braun C., Vogelgesang D., Ihling C., Hogerle S., Mix M. et al.: "Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET". Radiology, 2001, 218, 776.
9. Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B.: "Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study". Cancer, 1987, 60, 2035.
10. Hardesty L.A., Sumkin J.H., Nath M.E., Edwards R.P., Price F.V., Chang T.S. et al.: "Use of preoperative MR imaging in the management of endometrial carcinoma: cost analysis". Radiology, 2000, 215, 45.
11. Chung H.H., Kim J.W., Park N.H., Song Y.S., Kang S.B., Lee H.P.: "Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer". Acta Obstet. Gynecol. Scand., 2006, 85, 1501.
12. Hsieh C.H., ChangChien C.C., Lin H., Huang E.Y., Huang C.C., Lan K.C. et al.: "Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?". Gynecol. Oncol., 2002, 86, 28.
13. Doering D.L., Barnhill D.R., Weiser E.B., Burke T.W., Woodward J.E., Park R.C.: "Intraoperative evaluation of depth of myometrial invasion in Stage I endometrial adenocarcinoma". Obstet. Gynecol., 1989, 74, 930.
14. Kamura T., Yahata H., Shigematsu T., Ogawa S., Amada S., Kaku T. et al.: "Predicting pelvic lymph node metastasis in endometrial carcinoma". Gynecol. Oncol., 1999, 72, 387.
15. Hricak H., Rubinstein L. V., Gherman G. M., Karstaedt N.: "MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study". Radiology, 1991, 179, 829.
16. Williams A.D., Cousins C., Soutter W.P., Mubashar M., Peters A.M., Dina R. et al.: "Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography". AJR Am. J. Roentgenol., 2001, 177, 343.
17. Horowitz N.S., Dehdashti F., Herzog T.J., Rader J.S., Powell M.A., Gibb R.K. et al.: "Prospective evaluation of FDG-PET for detecting pelvic and paraaortic lymph node metastasis in uterine corpus cancer". Gynecol. Oncol., 2004, 95, 546.
18. Manfredi R., Mirk P., Maresca G., Margariti P.A., Testa A., Zannoni G.F. et al.: "Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning". Radiology, 2004, 231, 372.
19. Rockall A.G., Sohaib S.A., Harisinghani M.G., Babar S.A., Singh N., Jeyarajah A.R. et al.: "Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer". J. Clin. Oncol., 2005, 23, 2813.
20. Nakamoto Y., Saga T., Fujii S.: "Positron emission tomography application for gynecologic tumors". Int. J. Gynecol. Cancer, 2005, 15, 701.